ATAI Life Sciences N.V. Common Shares
Symbol: ATAI (NASDAQ)
3.03
▼ (-19.12%) -0.715
Company Description:
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
Key Stats
- Today's Open: $3.7
- Today's High: $3.84
- Today's Low: $2.44
- Today's Volume: 7.53M
- Yesterday Close: $3.74
- Yesterday High: $4
- Yesterday Low: $3.7
- Yesterday Volume: 7.40M
- Last Min Volume: 210
- Last Min High: $3.025
- Last Min Low: $3.025
- Last Min VWAP: $3.025
Company Profile
- Name: ATAI Life Sciences N.V. Common Shares
- Website: https://www.atai.life
- Listed Date: 2021-06-18
- Location: BERLIN, 2M
- Market Status: Active
- CIK Number: 0001840904
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $757.35M
- Round Lot: 100
- Outstanding Shares: 212.14M
- Asset Type: CS
RECENT FILINGS FOR ATAI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-02 | 144 | View |
| 2025-07-02 | DEFA14A | View |
| 2025-07-02 | DEFA14A | View |
| 2025-07-01 | 144 | View |
| 2025-07-01 | 8-K | View |
| 2025-07-01 | DEFA14A | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-18 | DEFA14A | View |
| 2025-06-04 | SCHEDULE 13D/A | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 144 | View |
| 2025-06-03 | DEFA14A | View |
| 2025-06-02 | DEFA14A | View |
| 2025-06-02 | DEFA14A | View |
Latest News on ATAI